Focus:
Analysis
-
November’s top news stories
Novartis has signed a definitive agreement to acquire The Medicines Company for a total consideration of $9.7bn, and China’s National Healthcare Security Administration (NHSA) has announced it has agreed an...
-
Q&A: Gavi alliance talks immunising 300 million people
Gavi, the Vaccine Alliance, has initiated a $7.4bn fundraising drive to support the immunisation of 300 million children against 18 diseases, which they say could save up to eight million...
-
Medidata NEXT NYC: designing trial software with patients in mind
At its New York City NEXT conference, Medidata focused on the excitement surrounding its recent acquisition by Dassault and its 2020 product launches. Rave Patient Portal, backed up by patient...
-
Recurrent miscarriage: could this devastating condition have a simple cure?
Recurrent miscarriages are often caused by endometriosis, a condition that affects one in ten women and leads to inflammation and lesions within the womb lining. Researchers now believe the condition...
-
The problem of manipulated data
In August, the FDA accused Novartis of submitting a drug application with manipulated data and then not informing regulators of the issue until a month after approval. According to the...
-
A safer ride: the latest innovation in targeted cancer treatment
One downside of the antibody-drug conjugates used in oncology today is that the drug-carrying antibodies can shed much of their toxic cargo on the way to the tumour site. Now,...
-
Debate: should countries bring critical drug production home?
Regulatory breaches at drug manufacturing sites in India and China have fuelled concerns over the safety of the API supply chain and sparked calls for countries to repatriate production of...
-
Making immunotherapy effective in pancreatic cancer
Immunotherapies have transformed treatment of cancers over the past few decades, but one cancer type that has not benefited has been pancreatic cancer, making this yet another example of the...
-
UK general election 2019: what are the parties’ promises to pharma?
As the UK approaches a December election, the Liberal Democrats, Labour and the Conservatives have published their manifestos. The NHS is central to all three parties’ promises to the people,...
-
Beyond Viagra Town: profiling the Irish pharma industry
The vast majority of the world’s supply of Viagra is manufactured by Pfizer in a small village in County Cork, Ireland, Leading to comical rumours that the vapours of the...